204 related articles for article (PubMed ID: 33438240)
1. Multimodal Biomarkers Quantify Recovery in Autoimmune Autonomic Ganglionopathy.
Koay S; Vichayanrat E; Bremner F; Panicker JN; Lang B; Lunn MP; Watson L; Ingle GT; Hagen EM; McNamara P; Jacobson L; Provitera V; Nolano M; Vincent A; Mathias CJ; Iodice V
Ann Neurol; 2021 Apr; 89(4):753-768. PubMed ID: 33438240
[TBL] [Abstract][Full Text] [Related]
2. [Anti-Ganglionic Acetylcholine Receptor Antibodies, Autoimmune Autonomic Ganglionopathy, and Related Disorders].
Nakane S; Watari M; Ando Y
Brain Nerve; 2018 Apr; 70(4):383-393. PubMed ID: 29632286
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy.
Nakane S; Mukaino A; Higuchi O; Yasuhiro M; Takamatsu K; Yamakawa M; Watari M; Tawara N; Nakahara KI; Kawakami A; Matsuo H; Ando Y
J Autoimmun; 2020 Mar; 108():102403. PubMed ID: 31924415
[TBL] [Abstract][Full Text] [Related]
4. Seronegative autoimmune autonomic neuropathy: a distinct clinical entity.
Golden EP; Bryarly MA; Vernino S
Clin Auton Res; 2018 Feb; 28(1):115-123. PubMed ID: 29280036
[TBL] [Abstract][Full Text] [Related]
5. Sudomotor dysfunction in autoimmune autonomic ganglionopathy.
Kimpinski K; Iodice V; Sandroni P; Fealey RD; Vernino S; Low PA
Neurology; 2009 Nov; 73(18):1501-6. PubMed ID: 19884578
[TBL] [Abstract][Full Text] [Related]
6. [Autoimmune autonomic ganglionopathy].
Nakane S
Rinsho Shinkeigaku; 2019 Dec; 59(12):783-790. PubMed ID: 31761837
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients.
Nakane S; Higuchi O; Koga M; Kanda T; Murata K; Suzuki T; Kurono H; Kunimoto M; Kaida K; Mukaino A; Sakai W; Maeda Y; Matsuo H
PLoS One; 2015; 10(3):e0118312. PubMed ID: 25790156
[TBL] [Abstract][Full Text] [Related]
8. [Over 5 years follow-up of three cases of autoimmune autonomic ganglionopathy].
Kurono H; Torikai Y; Hara H; Okamura M; Kunimoto M
Rinsho Shinkeigaku; 2022 Nov; 62(11):860-864. PubMed ID: 36288969
[TBL] [Abstract][Full Text] [Related]
9. Antibody titers predict clinical features of autoimmune autonomic ganglionopathy.
Gibbons CH; Freeman R
Auton Neurosci; 2009 Mar; 146(1-2):8-12. PubMed ID: 19144572
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic treatment dilemma: baroreflex failure or autoimmune autonomic ganglionopathy?
Farrell MC; Brenner AS; Shibao CA
Clin Auton Res; 2018 Dec; 28(6):589-591. PubMed ID: 30151691
[No Abstract] [Full Text] [Related]
11. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy.
Vernino S; Hopkins S; Wang Z
Auton Neurosci; 2009 Mar; 146(1-2):3-7. PubMed ID: 18951069
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune autonomic ganglionopathy].
Nakane S
Rinsho Shinkeigaku; 2013; 53(11):1071-3. PubMed ID: 24291882
[TBL] [Abstract][Full Text] [Related]
13. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy.
Gibbons CH; Vernino SA; Freeman R
Arch Neurol; 2008 Feb; 65(2):213-7. PubMed ID: 18268189
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma.
Hollenbeck R; Black BK; Peltier AC; Biaggioni I; Robertson D; Winton EF; Raj SR
Arch Neurol; 2011 Mar; 68(3):372-5. PubMed ID: 21059985
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune autonomic ganglionopathy with reversible cognitive impairment.
Gibbons CH; Centi J; Vernino S; Freeman R
Arch Neurol; 2012 Apr; 69(4):461-6. PubMed ID: 22158721
[TBL] [Abstract][Full Text] [Related]
16. Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy after mRNA COVID19 vaccination.
Rowe S; Spies JM; Urriola N
Autoimmun Rev; 2022 Dec; 21(12):103201. PubMed ID: 36210629
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature.
de Rojas Leal C; Lage-Sánchez JM; Pinel-Ríos J; León Plaza O; Hamad-Cueto O; Dawid de Vera MT; Dawid-Milner MS
Neurol Sci; 2022 Aug; 43(8):4841-4845. PubMed ID: 35482157
[TBL] [Abstract][Full Text] [Related]
18. Autonomic dysfunction following COVID-19 infection: an early experience.
Shouman K; Vanichkachorn G; Cheshire WP; Suarez MD; Shelly S; Lamotte GJ; Sandroni P; Benarroch EE; Berini SE; Cutsforth-Gregory JK; Coon EA; Mauermann ML; Low PA; Singer W
Clin Auton Res; 2021 Jun; 31(3):385-394. PubMed ID: 33860871
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center.
Li Y; Jammoul A; Mente K; Li J; Shields RW; Vernino S; Rae-Grant A
Muscle Nerve; 2015 Sep; 52(3):386-91. PubMed ID: 25557122
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune autonomic ganglionopathy: Ganglionic acetylcholine receptor autoantibodies.
Urriola N; Adelstein S
Autoimmun Rev; 2022 Feb; 21(2):102988. PubMed ID: 34728435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
